Our findings unravel a new direct contribution of LC to AD‐associated IL‐1β and IL‐18 under these conditions and shed light on the mechanistical role of SOCS1 and the mode of action of JAK inhibitors. The gene discussed is IL18; the disease is Alzheimer disease.